These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 1311618

  • 1. Increased hypothalamic [3H]flunitrazepam binding in hypothalamic-pituitary-adrenal axis hyporesponsive Lewis rats.
    Smith CC, Hauser E, Renaud NK, Leff A, Aksentijevich S, Chrousos GP, Wilder RL, Gold PW, Sternberg EM.
    Brain Res; 1992 Jan 13; 569(2):295-9. PubMed ID: 1311618
    [Abstract] [Full Text] [Related]

  • 2. Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis.
    Oitzl MS, van Haarst AD, Sutanto W, de Kloet ER.
    Psychoneuroendocrinology; 1995 Jan 13; 20(6):655-75. PubMed ID: 8584606
    [Abstract] [Full Text] [Related]

  • 3. Stress response, adrenal steroid receptor levels and corticosteroid-binding globulin levels--a comparison between Sprague-Dawley, Fischer 344 and Lewis rats.
    Dhabhar FS, McEwen BS, Spencer RL.
    Brain Res; 1993 Jul 09; 616(1-2):89-98. PubMed ID: 8395308
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats.
    Sternberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ, Gold PW, Wilder RL.
    Proc Natl Acad Sci U S A; 1989 Apr 09; 86(7):2374-8. PubMed ID: 2538840
    [Abstract] [Full Text] [Related]

  • 7. Increased plasma concentrations, hypothalamic content, and in vitro release of arginine vasopressin in inflammatory disease-prone, hypothalamic corticotropin-releasing hormone-deficient Lewis rats.
    Patchev VK, Kalogeras KT, Zelazowski P, Wilder RL, Chrousos GP.
    Endocrinology; 1992 Sep 09; 131(3):1453-7. PubMed ID: 1505475
    [Abstract] [Full Text] [Related]

  • 8. Hippocampal 8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding site densities, serotonin receptor (5-HT1A) messenger ribonucleic acid abundance, and serotonin levels parallel the activity of the hypothalamopituitary-adrenal axis in rat.
    Burnet PW, Mefford IN, Smith CC, Gold PW, Sternberg EM.
    J Neurochem; 1992 Sep 09; 59(3):1062-70. PubMed ID: 1379629
    [Abstract] [Full Text] [Related]

  • 9. In vitro regulation of pituitary ACTH secretion in inflammatory disease susceptible Lewis (LEW/N) and inflammatory disease resistant Fischer (F344/N) rats.
    Zelazowski P, Smith MA, Gold PW, Chrousos GP, Wilder RL, Sternberg EM.
    Neuroendocrinology; 1992 Oct 09; 56(4):474-82. PubMed ID: 1335552
    [Abstract] [Full Text] [Related]

  • 10. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats.
    Sternberg EM, Young WS, Bernardini R, Calogero AE, Chrousos GP, Gold PW, Wilder RL.
    Proc Natl Acad Sci U S A; 1989 Jun 09; 86(12):4771-5. PubMed ID: 2786636
    [Abstract] [Full Text] [Related]

  • 11. Strain differences in hypothalamic-pituitary-adrenal activity and stress ulcer.
    Redei E, Paré WP, Aird F, Kluczynski J.
    Am J Physiol; 1994 Feb 09; 266(2 Pt 2):R353-60. PubMed ID: 8141389
    [Abstract] [Full Text] [Related]

  • 12. Dexamethasone suppression of the effects of cocaine on adrenocortical secretion in Lewis and Fischer rats.
    Simar MR, Saphier D, Goeders NE.
    Psychoneuroendocrinology; 1997 Apr 09; 22(3):141-53. PubMed ID: 9203225
    [Abstract] [Full Text] [Related]

  • 13. Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone.
    Calogero AE, Sternberg EM, Bagdy G, Smith C, Bernardini R, Aksentijevich S, Wilder RL, Gold PW, Chrousos GP.
    Neuroendocrinology; 1992 May 09; 55(5):600-8. PubMed ID: 1350069
    [Abstract] [Full Text] [Related]

  • 14. The pulsatile characteristics of hypothalamo-pituitary-adrenal activity in female Lewis and Fischer 344 rats and its relationship to differential stress responses.
    Windle RJ, Wood SA, Lightman SL, Ingram CD.
    Endocrinology; 1998 Oct 09; 139(10):4044-52. PubMed ID: 9751481
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differential impact of stress on hypothalamic-pituitary-adrenal axis: gene expression changes in Lewis and Fisher rats.
    Ergang P, Vodička M, Soták M, Klusoňová P, Behuliak M, Řeháková L, Zach P, Pácha J.
    Psychoneuroendocrinology; 2015 Mar 09; 53():49-59. PubMed ID: 25591115
    [Abstract] [Full Text] [Related]

  • 18. Release of hypothalamic corticotropin-releasing hormone and arginine-vasopressin by interleukin 1 beta and alpha MSH: studies in rats with different susceptibility to inflammatory disease.
    Zelazowski P, Patchev VK, Zelazowska EB, Chrousos GP, Gold PW, Sternberg EM.
    Brain Res; 1993 Dec 17; 631(1):22-6. PubMed ID: 8298992
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.